Ratings Bank of America Corporation Nyse

Equities

BAC.PRE

US0605058157

Market Closed - Nyse Other stock markets 04:00:02 2024-05-06 pm EDT			5-day change	1st Jan Change
23.57 ^USD	+0.55%		+0.60%	+2.93%

10:52am	AstraZeneca target raised; Antofagasta lowered	AN
05:46am	Sanofi Close to Choosing BNP, BofA for Consumer Health Spinoff Deal	MT

Strengths

Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The company's share price in relation to its net book value makes it look relatively cheap.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Over the past four months, analysts' average price target has been revised upwards significantly.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
The average consensus view of analysts covering the stock has deteriorated over the past four months.

Ratings chart - Surperformance

Sector: Banks

	1st Jan change	Capi.	ESG Refinitiv
BANK OF AMERICA CORPORATION	+2.93%	295B	-
JPMORGAN CHASE & CO.	+12.87%	551B	C+
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED	+12.83%	249B	C+
WELLS FARGO & COMPANY	+22.29%	210B	C
BANK OF CHINA LIMITED	+19.80%	169B	B-
CHINA CONSTRUCTION BANK CORPORATION	+12.69%	170B	B-
HSBC HOLDINGS PLC	+11.85%	165B	C+
ROYAL BANK OF CANADA	+3.84%	144B	B-
HDFC BANK LIMITED	-11.88%	139B	B-
COMMONWEALTH BANK OF AUSTRALIA	+6.44%	129B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes